Inflation Reduction Act would grant Medicare the authority to negotiate drug prices and cap out-of-pocket costs at $2,000 per year.
This article is available to Insider Pro subscribers only. Sign in or register to be an Insider Pro and access ALL LOCKED articles.
Expand your Social Security knowledge with these four terms
Zurich reports 25% rise in first-half operating profit, on track to beat all targets
Username
Password
Remember Me
Expand your Social Security knowledge with these four terms
Zurich reports 25% rise in first-half operating profit, on track to beat all targets
Advisor News
- Panel: Is the American retirement system ‘broken’?
- Goldman Sachs, others weigh in on what’s ahead for the market in 2025
- How is consumers’ investing confidence impacting the need for advisors?
- Can a balance of withdrawals and annuities outshine the 4% rule?
- Economy ‘in a sweet spot’ but some concerns ahead
More Advisor NewsAnnuity News
Health/Employee Benefits News
- Opinion: Colorado must be a trailblazer on youth mental health services and solve the commercial insurance problem
- Why filling job openings will be crucial for Connecticut's economy in 2025
- The illusive sunny side
- How one doctor tried to take the profit motive out of health insurance
- Opinion: Scores of Alaskans face another eye-watering spike in their health care costs next year
More Health/Employee Benefits NewsLife Insurance News